Literature DB >> 34001982

End-tidal to arterial carbon dioxide gradient is associated with increased mortality in patients with traumatic brain injury: a retrospective observational study.

Pascal Doppmann1, Lorenz Meuli2, Stephen J M Sollid3, Miodrag Filipovic1, Jürgen Knapp4, Aristomenis Exadaktylos5, Roland Albrecht1,5,6, Urs Pietsch7,8,9.   

Abstract

Early definitive airway protection and normoventilation are key principles in the treatment of severe traumatic brain injury. These are currently guided by end tidal CO2 as a proxy for PaCO2. We assessed whether the difference between end tidal CO2 and PaCO2 at hospital admission is associated with in-hospital mortality. We conducted a retrospective observational cohort study of consecutive patients with traumatic brain injury who were intubated and transported by Helicopter Emergency Medical Services to a Level 1 trauma center between January 2014 and December 2019. We assessed the association between the CO2 gap-defined as the difference between end tidal CO2 and PaCO2-and in-hospital mortality using multivariate logistic regression models. 105 patients were included in this study. The mean ± SD CO2 gap at admission was 1.64 ± 1.09 kPa and significantly greater in non-survivors than survivors (2.26 ± 1.30 kPa vs. 1.42 ± 0.92 kPa, p < .001). The correlation between EtCO2 and PaCO2 at admission was low (Pearson's r = .287). The mean CO2 gap after 24 h was only 0.64 ± 0.82 kPa, and no longer significantly different between non-survivors and survivors. The multivariate logistic regression model showed that the CO2 gap was independently associated with increased mortality in this cohort and associated with a 2.7-fold increased mortality for every 1 kPa increase in the CO2 gap (OR 2.692, 95% CI 1.293 to 5.646, p = .009). This study demonstrates that the difference between EtCO2 and PaCO2 is significantly associated with in-hospital mortality in patients with traumatic brain injury. EtCO2 was significantly lower than PaCO2, making it an unreliable proxy for PaCO2 when aiming for normocapnic ventilation. The CO2 gap can lead to iatrogenic hypoventilation when normocapnic ventilation is aimed and might thereby increase in-hospital mortality.

Entities:  

Year:  2021        PMID: 34001982     DOI: 10.1038/s41598-021-89913-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  5 in total

1.  Respiratory dead space and arterial to end-tidal carbon dioxide tension difference in anesthetized man.

Authors:  J F NUNN; D W HILL
Journal:  J Appl Physiol       Date:  1960-05       Impact factor: 3.531

Review 2.  Cerebral blood flow, cerebral blood volume, and cerebrovascular reactivity after severe head injury.

Authors:  G J Bouma; J P Muizelaar
Journal:  J Neurotrauma       Date:  1992-03       Impact factor: 5.269

3.  Concordance between side-stream end-tidal carbon dioxide and arterial carbon dioxide partial pressure in respiratory service setting.

Authors:  Grace T S Law; C Y Wong; C W Kwan; K Y Wong; F P Wong; H N Tse
Journal:  Hong Kong Med J       Date:  2009-12       Impact factor: 2.227

4.  Deadspace and the single breath test for carbon dioxide during anaesthesia and artificial ventilation. Effects of tidal volume and frequency of respiration.

Authors:  R Fletcher; B Jonson
Journal:  Br J Anaesth       Date:  1984-02       Impact factor: 9.166

Review 5.  Cerebral blood flow in severe clinical head injury.

Authors:  G J Bouma; J P Muizelaar
Journal:  New Horiz       Date:  1995-08
  5 in total
  2 in total

1.  Airway management in a Helicopter Emergency Medical Service (HEMS): a retrospective observational study of 365 out-of-hospital intubations.

Authors:  Urs Pietsch; Raphael Müllner; Lorenz Theiler; Volker Wenzel; Lorenz Meuli; Jürgen Knapp; Stephen J M Sollid; Roland Albrecht
Journal:  BMC Emerg Med       Date:  2022-02-08

Review 2.  Diagnostic Modalities in Critical Care: Point-of-Care Approach.

Authors:  Sasa Rajsic; Robert Breitkopf; Mirjam Bachler; Benedikt Treml
Journal:  Diagnostics (Basel)       Date:  2021-11-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.